Diseases of the Colon & Rectum

, Volume 44, Issue 9, pp 1268–1273 | Cite as

Extended follow-up of patients treated with cytotoxic chemotherapy for intra-abdominal desmoid tumors

  • Lisa S. Poritz
  • Martin Blackstein
  • Terri Berk
  • Steve Gallinger
  • Robin S. McLeod
  • Zane Cohen
Original Contributions


BACKGROUND: Cytotoxic chemotherapy can achieve a good initial response in inoperable desmoid tumors that have caused progressive obstruction of the gastrointestinal and urinary tracts and have caused unrelenting pain. METHODS: We have reviewed 8 patients (3 male) with desmoid tumors and familial adenomatous polyposis who underwent cytotoxic chemotherapy for inoperable gastrointestinal obstruction and/or uncontrolled pain. They were treated with doxorubicin and dacarbazine followed by carboplatin and dacarbazine. RESULTS: Follow-up after cytotoxic chemotherapy in the 7 patients for whom it was available was a mean of 42 (range 24–54) months. Two patients achieved complete remission after therapy. Four patients achieved a partial remission after completing all or some of the chemotherapy regimen; of these, three remained in stable remission, whereas the other was lost to follow-up. There were two recurrences that required further therapy; one of these patients was treated with further chemotherapy, which induced a second remission, and the other was treated with pelvic exenteration and has subsequently died. CONCLUSIONS: Most patients had a substantial response to cytotoxic chemotherapy; however, two patients required additional therapy 24 and 30 months after cytotoxic chemotherapy, respectively. Cytotoxic chemotherapy is effective in producing short-term and long-term remission in these difficult patients.

Key words

Desmoid tumors Familial adenomatous polyposis Cytotoxic chemotherapy 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lewis JJ, Boland PJ, Leung DH, Woodruff JM, Brennan MF. The enigma of desmoid tumors. Ann Surg 1999;229:866–73.Google Scholar
  2. 2.
    Arvanitis ML, Jagelman DG, Fazio VW, Lavery IC, McGannon E. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990;33:639–42.Google Scholar
  3. 3.
    Pack GT, Ehrlich HE. Neoplasms of the anterior abdominal wall with special consideration to desmoid tumours: experience with 391 cases and collective review of the literature. Int Abstr Surg 1944;79:177–98.Google Scholar
  4. 4.
    Dahn I, Jonsson N, Lundh G. Desmoid tumours: a series of 33 cases. Acta Chir Scand 1963;126:305–14.Google Scholar
  5. 5.
    Merchant NB, Lewis JJ, Woodruff JM, Leung DH, Brennan MF. Extremity and trunk desmoid tumors. Cancer 1999;86:2045–52.Google Scholar
  6. 6.
    Reitamo JJ, Hayry P, Nykyri E, Saxen E. The desmoid tumor: I. Incidence, sex-, age-, and anatomical distribution in the Finnish population. Am J Clin Pathol 1982;77:665–73.Google Scholar
  7. 7.
    Rodriguez-Bias MA, Mahoney MC, Karakousis CP, Petrelli NJ. Desmoid tumors in patients with familial adenomatous polyposis. Cancer 1994;74:1270–4.Google Scholar
  8. 8.
    Jones IT, Jagelman DG, Fazio VW, Lavery IC, Weakley FL, McGannon E. Desmoid tumors in familial polyposis coli. Ann Surg 1986;204:94–7.Google Scholar
  9. 9.
    Schnitzler M, Cohen Z, Blackstein M,et al. Chemotherapy for desmoid tumors in association with familial adenomatous polyposis. Dis Colon Rectum 1997;40:798–801.Google Scholar
  10. 10.
    Hamilton L, Blackstein M, Berk T,et al. Chemotherapy for desmoid tumors in association with familial adenomatous polyposis: a report of three cases. Can J Surg 1996;39:247–52.Google Scholar
  11. 11.
    Easter DW, Halasz NA. Recent trends in the management of desmoid tumors: summary of 19 cases and review of the literature. Ann Surg 1989;210:765–9.Google Scholar
  12. 12.
    Berk T, Cohen Z, McLeod RS, Stern HS. Management of mesenteric desmoid tumours in familial adenomatous polyposis. Can J Surg 1992;35:393–5.Google Scholar
  13. 13.
    Tsukada K, Church JM, Jagelman DG, Fazio VW, Lavery IC. Systemic cytotoxic chemotherapy and radiation therapy for desmoid in familial adenomatous polyposis. Dis Colon Rectum 1991;34:1090–2.Google Scholar
  14. 14.
    Lim CL, Walker MJ, Mehta RR, Das GT. Estrogen and antiestrogen binding sites in desmoid tumors. Eur J Cancer Clin Oncol 1986;22:583–7.Google Scholar
  15. 15.
    Belliveau P, Graham AM. Mesenteric desmoid tumor in Gardner's syndrome treated by sulindac. Dis Colon Rectum 1984;27:53–4.Google Scholar
  16. 16.
    Soravia C, Berk T, McLeod RS, Cohen Z. Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum 2000;43:363–9.Google Scholar
  17. 17.
    Khorsand J, Karakousis CP. Desmoid tumors and their management. Am J Surg 1985;149:215–8.Google Scholar
  18. 18.
    Hutchinson RJ, Norris DG, Schnauffer L. Chemotherapy: a successful application in abdominal fibromatosis. Pediatrics 1979;63:157–9.Google Scholar
  19. 19.
    Kitamura A, Kanagawa T, Yamada S, Kawai T. Effective chemotherapy for abdominal desmoid tumor in a patient with Gardner's syndrome: report of a case. Dis Colon Rectum 1991;34:822–6.Google Scholar
  20. 20.
    Seiter K, Kemeny N. Successful treatment of a desmoid tumor with doxorubicin. Cancer 1993;71:2242–4.Google Scholar
  21. 21.
    Lynch HT, Fitzgibbons R Jr, Chong S,et al. Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in Gardner's syndrome. Dis Colon Rectum 1994;37:260–7.Google Scholar
  22. 22.
    Patel SR, Evans HL, Benjamin RS. Combination chemotherapy in adult desmoid tumors. Cancer 1993;72:3244–7.Google Scholar
  23. 23.
    Borden EC, Amato D, Enterline HT,et al. Randomized comparison of adriamycin regimens for treatment of soft tissue sarcomas. J Clin Oncol 1987;5:840–50.Google Scholar

Copyright information

© The American Society of Colon and Rectal Surgeons 2001

Authors and Affiliations

  • Lisa S. Poritz
    • 1
  • Martin Blackstein
    • 1
  • Terri Berk
    • 1
  • Steve Gallinger
    • 1
  • Robin S. McLeod
    • 1
  • Zane Cohen
    • 1
  1. 1.From the Steve Atanas Starvo Familial Gastrointestinal Cancer Registry, Mount Sinai Hospital and theUniversity of TorontoTorontoCanada

Personalised recommendations